Natixis »

Abeona Therapeutics shares owned by Natixis

Quarter-by-quarter ownership of Abeona Therapeutics (ABEO) shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Abeona Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Abeona Therapeutics held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abeona Therapeutics by Natixis

Quarter filed Position value Share count Share price at filing
2026-06-30 $116k 20k 5.93

More positions owned by Natixis

Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Micron Technology (MU)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Tesla Motors (TSLA)
Spdr Series Trust St Str P500etf (SPYM)
Energy Transfer Com Ut Ltd Ptn (ET)
Broadcom (AVGO)
Oracle Corporation (ORCL)
JPMorgan Chase & Co. (JPM)

View all positions for Natixis

Top funds holding Abeona Therapeutics

Nantahala Capital Management
BlackRock
Cable Car Capital
AIGH Capital Management
Vanguard Capital Management
Resources Investment Advisors
AWM Investment Company
Geode Capital Management
Kennedy Capital Management
Goldman Sachs Group
Propel Bio Management
State Street Corporation
Nan Fung Trinity
Diametric Capital
J. Goldman & Co

View all funds holding Abeona Therapeutics